FDA
-
-
-
-
-
-
-
Zoetis Announces Third Quarter 2025 Results
-
-
-
-
-
-
-
Zoetis (ZTS) Announces U.S. Label Update for Librela, a Treatment to Control Canine Osteoarthritis (OA) Pain
-
-
-
-
-
-
-
Zoetis (ZTS) stock drops following WSJ report on pet arthritis drugs
-
-
-
-
-
-
-
Zoetis (ZTS) Receives FDA Approval for Solensia
-
-
-
-
-
-
-
Zoetis Announces Second Quarter 2019 Results
-
-
-
-
-
-
328,603 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

